Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/04/2007WO2007111163A1 Nanocomposite particle
10/04/2007WO2007111038A1 Aggrecanase production inhibitor
10/04/2007WO2007111027A1 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
10/04/2007WO2007111023A1 Hydrate for medical purposes
10/04/2007WO2007110977A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical
10/04/2007WO2007110876A2 Novel sulfonanilide derivatives, pharmaceutical compositions comprising the same and process thereof
10/04/2007WO2007110875A1 Antibiotic compositions of modified release and process of production thereof
10/04/2007WO2007110834A2 Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
10/04/2007WO2007110811A2 Use of the staudinger ligation in in vivo assembly of a biologically active compound
10/04/2007WO2007110782A1 Muscarinic receptor antagonists
10/04/2007WO2007110778A2 Mucosal bioadhesive slow release carrier for delivering active principles
10/04/2007WO2007110761A2 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
10/04/2007WO2007110755A1 Prophylaxis or treatment of cardiovascular inflammation
10/04/2007WO2007110745A1 Combination therapy for treatment of cancer
10/04/2007WO2007110730A2 Varenicline standards and impurity controls
10/04/2007WO2007110727A2 Amide stabilized hydroxyethylamines
10/04/2007WO2007110701A2 Foldable igniter
10/04/2007WO2007110667A1 Piperidines and related compounds for the treatment of dementia
10/04/2007WO2007110636A1 Buprenorphine derivatives and uses thereof
10/04/2007WO2007110630A1 Thioninium compounds and their use
10/04/2007WO2007110629A1 Inhibitors of protein aggregation
10/04/2007WO2007110627A2 3,7-diamino-10h-phenothiazine salts and their use
10/04/2007WO2007110559A1 Pharmaceutically acceptable salts and polymorphic forms of sildenafil
10/04/2007WO2007110500A1 Use of canthin-6-one and its analogues in the treatment of pathologies linked to mycobacteria
10/04/2007WO2007110450A1 Method of predicting survival of a non-small-cell lung cancer patient to a chemotherapeutic treatment
10/04/2007WO2007110449A1 Benzenesulfonamide compounds and their use
10/04/2007WO2007110438A1 Imidazo [1,2 -b] pyridazines, their processes of preparation and their use as gaba receptor ligands
10/04/2007WO2007110437A1 Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands
10/04/2007WO2007110418A2 Substituted 5-hetaryl-4-aminopyrimidines
10/04/2007WO2007110380A1 Insect bite relief preparation comprising epinastine
10/04/2007WO2007110364A1 Benzothiazoles having histamine h3 receptor activity
10/04/2007WO2007110356A1 Spray composition for topical use for treating and/or preventing herpes simplex labial infections
10/04/2007WO2007110344A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
10/04/2007WO2007110337A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/04/2007WO2007110335A1 Malonamide derivatives as gamma secretase inhibitors
10/04/2007WO2007110243A1 Medicament, cosmetic or food product comprising an indol compound, the use thereof and the method of isolation thereof from sauerkraut
10/04/2007WO2007110241A1 Plant extracts, plant components and the uses thereof
10/04/2007WO2007110226A1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists
10/04/2007WO2007110225A1 Improved crystalline material
10/04/2007WO2007110221A1 Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
10/04/2007WO2007110220A1 USE OF 4,9-ANHYDRO-TETRODOTOXIN FOR THE TREATMENT OF DISEASES RELATED TO THE VOLTAGE-GATED SODIUM CHANNEL α SUBUNIT NAV 1.6
10/04/2007WO2007110216A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
10/04/2007WO2007110215A1 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase
10/04/2007WO2007110214A1 12-aza-ep0thil0nes, process for their preparation and their use as antiproliferative agents
10/04/2007WO2007110209A1 Biological materials and uses thereof
10/04/2007WO2007110171A1 Substituted n-benzyl-n-phenylbenzenesulphonamides for treating viral infections
10/04/2007WO2007110152A2 Polylactide nanoparticles
10/04/2007WO2007110109A1 Novel method
10/04/2007WO2007110047A2 TERGURIDE/PROTERGURIDE FOR THE TREATMENT OF CHRONIC PAIN (e.g. MIGRAINE)
10/04/2007WO2007109884A1 Fat-trapping composition comprising an indigestible cationic polysaccharide and an emulsifying agent
10/04/2007WO2007109882A1 Anti-diabetic cataract compounds and their uses
10/04/2007WO2007109871A2 Acridine derivatives with antitumoral activity
10/04/2007WO2007109870A1 Veterinary composition comprising an insect growth regulator, in particular a benzoylurea compound to control ectoparasites
10/04/2007WO2007109852A1 Selenium for treatment of cancer
10/04/2007WO2007109845A1 Prophylaxis or treatment of diabetes
10/04/2007WO2007109844A1 Anti-inflammatory metal complexes
10/04/2007WO2007109843A1 Metal complexes having anti-inflammatory activity
10/04/2007WO2007098384A3 Tetracyclic steroid derivatives useful as progesterone receptor modulators
10/04/2007WO2007095615A3 Use of benzo-heteroaryl sulfamide derivatives for the treatmentof pain
10/04/2007WO2007095601A3 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
10/04/2007WO2007093168A3 Rapid release irbesartan-containing pharmaceutical composition
10/04/2007WO2007092846A3 2-AMINO-3,4-DIHYDRO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)
10/04/2007WO2007092839A3 Macrocycle derivatives useful as inhibitors of beta-secretase (bace)
10/04/2007WO2007092645A3 Novel hcv inhibitor combinations and methods
10/04/2007WO2007091948A3 Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1
10/04/2007WO2007091947A3 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1
10/04/2007WO2007090881A3 Modified release formulation
10/04/2007WO2007085556A3 Use of 4-imidazole derivatives for cns disorders
10/04/2007WO2007084914A3 Phenoxy-substituted pyrimidines as adenosine receptor antagonists
10/04/2007WO2007084777A9 Multi-parameter monitoring device for use with central and intravenous administration of medication
10/04/2007WO2007084424A3 Treatment of substance abuse
10/04/2007WO2007082309A3 Adenosine monophosphate for inducing torpor in a subject
10/04/2007WO2007079999A3 Pyridopyrazine derivatives and use thereof as modulators of the signal transduction paths
10/04/2007WO2007077490A3 Bicyclic heteroaryl compounds as pde10 inhibitors
10/04/2007WO2007076005A3 Processes and intermediates useful for preparing integrase inhibitor compounds
10/04/2007WO2007075847A3 Glucokinase activators
10/04/2007WO2007074399A3 Process for the preparation of tetrazolyl compounds
10/04/2007WO2007072201A3 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/04/2007WO2007072164A3 Estrogen modulators
10/04/2007WO2007072163A3 Pyrimidine derivatives
10/04/2007WO2007071861A3 Compositions including at least one retinoid compound and at least one anti-irritant compound and uses thereof
10/04/2007WO2007071658A3 Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
10/04/2007WO2007069033A3 Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol
10/04/2007WO2007067581A8 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride
10/04/2007WO2007067053A9 Composition containing oligosaccharides for the treatment / prevention of infections
10/04/2007WO2007066216A3 Fatty acids profile correlated to the propensity or risk of breast cancer
10/04/2007WO2007066181A3 Methods of preparing a vegf-r inhibitor
10/04/2007WO2007064595A3 Fluocinolone acetonide drug substance polymorphic interconversion
10/04/2007WO2007063385A3 Spirocyclic amine histamine-3 receptor antagonists
10/04/2007WO2007063384A3 Pyrimidine derivatives for the treatment of abnormal cell growth
10/04/2007WO2007060525A3 Process for preparing bicyclic pyrazolyl and imidazolyl compounds
10/04/2007WO2007060215A3 (r)-arylkylamino derivatives and pharmaceutical compositions containing them
10/04/2007WO2007058935A3 Ophthalmic composition for dry eye therapy
10/04/2007WO2007058805A3 Compositions and methods for treating cns disorders
10/04/2007WO2007058639A3 Antibacterial agents
10/04/2007WO2007058568A3 Salts of 9-oxoacridine-10-acetic acid with 1-alkylamino-1-desoxy-polyols
10/04/2007WO2007056317A3 Methods for assaying an active pharmaceutical ingredient
10/04/2007WO2007056162A3 Methods of treating cancers with saha, carboplatin, and paclitaxel and other combination therapies
10/04/2007WO2007054831A3 Inhibitors of vegf receptor and hgf receptor signaling
10/04/2007WO2007054822A3 Use of at least one avermectin or milbemycin in the treatment of ophthalmic pathologies
1 ... 3555 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 3566 3567 3568 3569 3570 3571 3572 3573 3574 3575 ... 7860